11
12
13
14
15
16
S.A. van Laar, K.B. Gombert-Handoko, R.H.H. Groenwold, T. van der Hulle, L.E. Visser, D. Houtsma, H.J. Guchelaar, J. Zwaveling
Veröffentlicht in: Frontiers in Pharmacology, Vol 13 (2022);
2022
Veröffentlicht in: Frontiers in Pharmacology, Vol 13 (2022);
2022
17
18
Selvarajah, Abi, Tavenier, Annerieke H., Bor, Wilbert L., Houben, Vital, Rasoul, Saman, Kaplan, Eliza, Teeuwen, Koen, Hofma, Sjoerd H., Lipsic, Erik, Amoroso, Giovanni, van Leeuwen, Maarten A.H., ten Berg, Jur M., van ‚Äėt Hof, Arnoud W.J., Hermanides, Renicus S.
Veröffentlicht in: Selvarajah , A , Tavenier , A H , Bor , W L , Houben , V , Rasoul , S , Kaplan , E , Teeuwen , K , Hofma , S H , Lipsic , E , Amoroso , G , van Leeuwen , M A H , ten Berg , J M , van ‚Äėt Hof , A W J & Hermanides , R S 2021 , ' Feasibility and safety of cangrelor in patients with suboptimal P2Y 12 inhibition undergoing percutaneous coronary intervention : The Dutch Cangrelor registry ' , European Heart Journal Open , vol. 1 , no. 3 , 1‚Äď3 . https://doi.org/10.1093/ehjopen/oeab028;
2021
Veröffentlicht in: Selvarajah , A , Tavenier , A H , Bor , W L , Houben , V , Rasoul , S , Kaplan , E , Teeuwen , K , Hofma , S H , Lipsic , E , Amoroso , G , van Leeuwen , M A H , ten Berg , J M , van ‚Äėt Hof , A W J & Hermanides , R S 2021 , ' Feasibility and safety of cangrelor in patients with suboptimal P2Y 12 inhibition undergoing percutaneous coronary intervention : The Dutch Cangrelor registry ' , European Heart Journal Open , vol. 1 , no. 3 , 1‚Äď3 . https://doi.org/10.1093/ehjopen/oeab028;
2021
19
20